American Journal of Cardiovascular Drugs

, Volume 5, Issue 2, pp 71–81 | Cite as

Obstructive Sleep Apnea

What Does the Cardiovascular Physician Need to Know?
Current Opinion


Obstructive sleep apnea (OSA) is a common disorder in adults. It is becoming increasingly recognized as a risk factor for cardiovascular diseases such as hypertension, pulmonary hypertension, myocardial infarction, and stroke. Knowing the pathophysiologic effects that occur during obstructive apnea assists in understanding how chronic complications and sequelae develop. OSA is also being recognized as associated with glucose intolerance and motor vehicle accidents. Polysomnography in a sleep laboratory remains the diagnostic method of choice. Treatment options are somewhat limited in scope, but nasal continuous positive airway pressure is the first line and has been shown to clearly improve many of the symptoms and sequelae of the syndrome. Cardiovascular physicians require a working knowledge of OSA and its complications, as many of the diseases they manage have shown links to this sleep disorder.


  1. 1.
    Young T, Peppard P, Gottlieb D. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002; 165: 1217–39PubMedCrossRefGoogle Scholar
  2. 2.
    Bixler E, Vgontzas A, Lin H, et al. Prevalence of sleep-disordered breathing in women. Am J Respir Crit Care Med 2001; 163: 608–13PubMedGoogle Scholar
  3. 3.
    Redline S, Tishler P, Hans M, et al. Racial differences in sleep-disordered breathing in African-Americans and Caucasians. Am J Respir Crit Care Med 1997; 155: 186–92PubMedGoogle Scholar
  4. 4.
    Kripke D, Ancoli-Israel S, Klauber M, et al. Prevalence of sleep-disordered breathing in ages 40–64 years: a population-based survey. Sleep 1997; 20(1): 65–76PubMedGoogle Scholar
  5. 5.
    Young T, Shahar E, Nieto F, et al. Predictors of sleep-disordered breathing in community dwelling adults: the Sleep Heart Health Study. Arch Intern Med 2002; 162: 893–900PubMedCrossRefGoogle Scholar
  6. 6.
    Bixler E, Vgontzas A, Ten Have T, et al. Effects of age on sleep apnea in men: I. Prevalence and severity. Am J Respir Crit Care Med 1998; 157(1): 144–8PubMedGoogle Scholar
  7. 7.
    American Academy of Sleep Medicine Task Force. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 1999; 22: 667–89Google Scholar
  8. 8.
    Hoffstein V, Weiser W, Haney R. Roentgenographic dimensions of the upper airway in snoring patients with and without obstructive sleep apnea. Chest 1991; 100: 81–5PubMedCrossRefGoogle Scholar
  9. 9.
    Haponik E, Smith P, Bohlman M, et al. Computerized tomography in obstructive sleep apnea. Am Rev Respir Dis 1983; 127: 221–6PubMedGoogle Scholar
  10. 10.
    Abbey N, Block A, Green D, et al. Measurement of pharyngeal volume by digitized magnetic resonance imaging: effect of nasal CPAP. Am Rev Respir Dis 1989; 40(3): 717–23Google Scholar
  11. 11.
    Hoffstein V, Zamel N, Phillipson E. Lung volume dependence of pharyngeal cross-sectional area in patients with obstructive sleep apnea. Am Rev Respir Dis 1984; 130: 175–8PubMedGoogle Scholar
  12. 12.
    Mezzanotte W, Tangel D, White D. Waking genioglossus electromyogram in sleep apnea patients vs normal controls (a neuromuscular compensatory mechanism). J Clin Invest 1992; 89: 1571–9PubMedCrossRefGoogle Scholar
  13. 13.
    Van de Graaff W. Thoracic traction on the trachea: mechanisms and magnitude. J Appl Physiol 1991; 70: 1328–36PubMedGoogle Scholar
  14. 14.
    Larrson H, Carlson-Nordlander B, Lindblad L, et al. Temperature thresholds in the oropharynx of patient with obstructive sleep apnea syndrome. Am Rev Respir Dis 1992; 146: 1246–9Google Scholar
  15. 15.
    Kimoff R, Sforza E, Champagne V, et al. Upper airway sensation in snoring and obstructive sleep apnea. Am J Respir Crit Care Med 2001; 164: 250–5PubMedGoogle Scholar
  16. 16.
    Wasicko M, Hutt D, Parisi R, et al. The role of vascular tone in the control of upper airway collapsibility. Am Rev Respir Dis 1990; 141: 1569–77PubMedGoogle Scholar
  17. 17.
    Younes M, Ostrowski M, Thompson W, et al. Chemical control stability in patients with obstructive sleep apnea. Am J Respir Crit Care Med 2001; 163: 1181–90PubMedGoogle Scholar
  18. 18.
    Zwillich C, Devlin T, White D, et al. Bradycardia during sleep apnea: characteristics and mechanism. J Clin Invest 1982; 69: 1286–92PubMedCrossRefGoogle Scholar
  19. 19.
    Schafer H, Hasper E, Ewig S, et al. Pulmonary haemodynamics in obstructive sleep apnoea: time course and associated factors. Eur Respir J 1998; 12(3): 679–84PubMedCrossRefGoogle Scholar
  20. 20.
    Tilkain A, Guilleminault C, Schroeder J, et al. Hemodynamics in sleep induced apnea: studies during wakefulness and sleep. Ann Intern Med 1976; 85: 714–9Google Scholar
  21. 21.
    Guilleminault C, Motta J, Mihm F, et al. Obstructive sleep apnea and cardiac index. Chest 1986; 89: 331–4PubMedCrossRefGoogle Scholar
  22. 22.
    Garpestad E, Katayama H, et al. Stroke volume and cardiac output decrease at termination of obstructive apneas. J Appl Physiol 1992; 73(5): 1743–8PubMedGoogle Scholar
  23. 23.
    Hedner J, Ejnell H, Sellgren J, et al. Is high and fluctuating muscle nervous system activity in the sleep apnoea syndrome of pathogenetic importance for the development of hypertension? J Hypertens 1988; 6 Suppl. 4: S529–31Google Scholar
  24. 24.
    Somers V, Dyken M, Clary M, et al. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995; 96: 1897–904PubMedCrossRefGoogle Scholar
  25. 25.
    Netzer N, Werner P, Jochums I, et al. Blood flow of the middle cerebral artery with sleep-disordered breathing: correlation with obstructive hypopneas. Stroke 1998; 29(1): 87–93PubMedCrossRefGoogle Scholar
  26. 26.
    Jenum P, Borgesen S. Intracranial pressure and obstructive sleep apnea. Chest 1989; 95: 279–83CrossRefGoogle Scholar
  27. 27.
    Loeppky J, Voyles W, Eldridge M. Sleep apnea and autonomic cerebrovascular dysfunction. Sleep 1987; 10: 25–34PubMedGoogle Scholar
  28. 28.
    Shiomi T, Guilleminault C, Stoohs R, et al. Leftward shift of the interventricular septum and pulsus paradoxus in obstructive sleep apnea syndrome. Chest 1991; 100: 894–902PubMedCrossRefGoogle Scholar
  29. 29.
    Buda A, Pinsky M, Ingels N, et al. Effect of intrathoracic pressure on left ventricular performance. N Engl J Med 1979; 310: 453–9CrossRefGoogle Scholar
  30. 30.
    Gleeson K, Zwillich C, White D. The influence of increasing ventilatory effort on arousal from sleep. Am Rev Respir Dis 1990; 142: 295–300PubMedGoogle Scholar
  31. 31.
    Brooks L, Strohl K. Size and mechanical properties of the pharynx in healthy men and women. Am Rev Respir Dis 1992; 146: 1394–7PubMedGoogle Scholar
  32. 32.
    Mohsenin V. Gender differences in the expression of sleep-disordered breathing. Chest 2001; 120: 1442–7PubMedCrossRefGoogle Scholar
  33. 33.
    Whittle A, Marshall I, Mortimore I, et al. Neck and soft tissue and fat distribution: comparison between normal men and women by magnetic resonance imaging. Thorax 1999; 54: 323–8PubMedCrossRefGoogle Scholar
  34. 34.
    Popovic R, White D. Upper airway muscle activity in normal women: influence of hormonal status. J Appl Physiol 1998; 84(3): 1055–62PubMedGoogle Scholar
  35. 35.
    Pillar G, Malhotra A, Fogel R, et al. Airway mechanics and ventilation in response to resistive loading during sleep: influence of gender. Am J Respir Crit Care Med 2000; 162: 1627–3PubMedGoogle Scholar
  36. 36.
    O’Connor C, Thornley S, Hanly P. Gender differences in the polysomnographic features of obstructive sleep apnea. Am J Respir Crit Care Med 2000; 161: 145–72Google Scholar
  37. 37.
    Ware J, McBrayer R, Scott J. Influence of sex and age on duration and frequency of sleep apnea events. Sleep 2000; 23: 165–70PubMedGoogle Scholar
  38. 38.
    Peppard P, Young T, Palta M, et al. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA 2000; 284: 3105–21CrossRefGoogle Scholar
  39. 39.
    Davies R, Ali N, Stradling J. Neck circumference and other clinical features in the diagnosis of the obstructive sleep apnoea syndrome. Thorax 1992; 47: 101–5PubMedCrossRefGoogle Scholar
  40. 40.
    Fleetham JA. Upper airway imaging in relation to obstructive sleep apnea. Clin Chest Med 1992; 13: 399–416PubMedGoogle Scholar
  41. 41.
    Johns F, Strollo P, Buckley M, et al. The influence of craniofacial structure on obstructive sleep apnea in young adults. J Oral Maxillofac Surg 1998; 56: 596–602PubMedCrossRefGoogle Scholar
  42. 42.
    Nelson S, Hans M. Contribution of craniofacial risk factors in increasing apneic activity among obese and nonobese habitual snorers. Chest 1997; 111: 154–62PubMedCrossRefGoogle Scholar
  43. 43.
    Rappai M, Collop N, Kemp S, et al. The nose and sleep-disordered breathing: what we know and what we don’t know. Chest 2003; 124(6): 2309–23PubMedCrossRefGoogle Scholar
  44. 44.
    Schellenberg J, Maislin G, Schwab R. Physical findings and the risk for OSA: the importance of oropharyngeal structures. Am J Respir Crit Care Med 2000; 162: 740–8PubMedGoogle Scholar
  45. 45.
    Guilleminault C, Stoohs R, Kim Y, et al. Sleep-related upper airway disordered breathing in women. Ann Intern Med 1995; 122: 493–501PubMedGoogle Scholar
  46. 46.
    Gottlieb D, Whitney C, Bonekat W, et al. Relation of sleepiness to respiratory disturbance index: the Sleep Heart Health Study. Am J Respir Crit Care Med 1999; 159(2): 502–7PubMedGoogle Scholar
  47. 47.
    Johns M. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 1991; 14(6): 540–5PubMedGoogle Scholar
  48. 48.
    Lavie P, Yosef B, Rubin A. Prevalence of sleep apnea syndrome among patients with essential hypertension. Am Heart J 1984; 108: 373–6PubMedCrossRefGoogle Scholar
  49. 49.
    Kales A, Bixler E, Cadieux R, et al. Sleep apnea in a hypertensive population. Lancet 1984; II: 1005–8CrossRefGoogle Scholar
  50. 50.
    Fletcher E, DeBehnke R, Lovoi M, et al. Undiagnosed sleep apnea in patients with essential hypertension. Ann Intern Med 1985; 103: 190–5PubMedGoogle Scholar
  51. 51.
    Logan A, Perlikowski S, Mente A, et al. High prevalence of unrecognized sleep apnea in drug-resistant hypertension. J Hypertens 2001; 19: 2271–7PubMedCrossRefGoogle Scholar
  52. 52.
    Nieto F, Young T, Lind B, et al. Association of sleep-disordered breathing, sleep apnea and hypertension in a large community based study. JAMA 2000; 283: 1829–36PubMedCrossRefGoogle Scholar
  53. 53.
    Peppard P, Yong T, Palta M, et al. Population based study of the association between sleep disordered breathing and hypertension. N Engl J Med 2000; 342: 1378–84PubMedCrossRefGoogle Scholar
  54. 54.
    Lavie P, Hoffstein V. Sleep apnea syndrome: a possible contributing factor to resistant hypertension. Sleep 2001; 24(6): 721–5PubMedGoogle Scholar
  55. 55.
    Fletcher E, Miller J, Schaaf J, et al. Urinary catecholamines before and after tracheostomy in patients with obstructive sleep apnea and hypertension. Sleep 1987; 10: 35–44PubMedGoogle Scholar
  56. 56.
    Dimsdale J, Coy T, Ziegler M, et al. The effects of sleep apnea on plasma and urinary catecholamines. Sleep 1995; 18: 377–81PubMedGoogle Scholar
  57. 57.
    Carlson J, Rangemark C, Hedner J. Attenuated endothelium-dependent vascular relaxation in patients with sleep apnoea. J Hypertens 1996; 14: 577–84PubMedCrossRefGoogle Scholar
  58. 58.
    Narkiewicz K, Masahiko K, Phillips B, et al. Nocturnal CPAP decreases daytime sympathetic traffic in obstructive sleep apnea. Circulation 1999; 100: 2332–5PubMedCrossRefGoogle Scholar
  59. 59.
    Imodojemu V, Gleeson K, Quraishi S, et al. Impaired vasodilator responses in obstructive sleep apnea are improved with CPAP therapy. Am J Respir Crit Care Med 2002; 165: 950–3Google Scholar
  60. 60.
    Phillips B, Kato M, Narkiewicz K, et al. Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. Am J Physiol Heart Circ Physiol 2000; 279: H234–7PubMedGoogle Scholar
  61. 61.
    Shek E, Brands M, Hall J. Chronic leptin infusion increases arterial pressure. Hypertension 1998; 31: 409–14PubMedCrossRefGoogle Scholar
  62. 62.
    Becker H, Jerrentrup A, Ploch T, et al. Effect of nasal CPAP treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003; 107: 68–73PubMedCrossRefGoogle Scholar
  63. 63.
    Kreiger J, Sforza E, Apprill M, et al. Pulmonary hypertension, hypoxemia and hypercapnia in obstructive sleep apnea patients. Chest 1989; 96: 729–37CrossRefGoogle Scholar
  64. 64.
    Chaouat A, Weitzenblum E, Krieger J, et al. Pulmonary hemodynamics in the obstructive sleep apnea syndrome: results in 220 consecutive patients. Chest 1996; 109: 380–6PubMedCrossRefGoogle Scholar
  65. 65.
    Sajkov D, Cowie R, Thornton A, et al. Pulmonary hypertension and hypoxemia in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 1994; 149: 416–22PubMedGoogle Scholar
  66. 66.
    Fletcher E, Schaaf J, Miller J, et al. Long-term cardiopulmonary sequelae in patients with sleep apnea and chronic lung disease. Am Rev Respir Dis 1987; 135: 525–33PubMedGoogle Scholar
  67. 67.
    Chauout A, Weitzenblum E, Krieger J, et al. Association of chronic obstructive lung disease and sleep apnea syndrome. Am J Respir Crit Care Med 1995; 151: 82–6Google Scholar
  68. 68.
    Kessler R, Chaouat A, Weitzenblum E, et al. Pulmonary hypertension in the obstructive sleep apnoea syndrome: prevalence, causes and therapeutic consequences. Eur Respir J 1996; 9: 787–94PubMedCrossRefGoogle Scholar
  69. 69.
    Elmasry A, Janson C, Lindberg E, et al. The role of habitual snoring and obesity in the development of diabetes: a 10-year follow-up study in a male population. J Intern Med 2000; 248: 13–20PubMedCrossRefGoogle Scholar
  70. 70.
    Punjabi N, Sorkin J, Katzel L, et al. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 2002; 165: 677–82PubMedGoogle Scholar
  71. 71.
    Ip M, Lam B, Mg M, et al. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 2002; 165: 670–6PubMedGoogle Scholar
  72. 72.
    Spiegal K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet 1999; 354: 1435–9CrossRefGoogle Scholar
  73. 73.
    Vgontzas A, Papanicolaou D, Bixler E, et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance and hypercytokinemia. J Clin Endocrinol Metab 2000; 85: 1151–8PubMedCrossRefGoogle Scholar
  74. 74.
    Shinohara E, Kihara S, Yamashita S, et al. Visceral fat accumulation as an important risk factor for obstructive sleep apnoea syndrome in obese subjects. J Intern Med 1997; 241: 11–8PubMedCrossRefGoogle Scholar
  75. 75.
    Vgontzas A, Bixler E, Chrousos G. Metabolic disturbances on obesity vs sleep apnoea: the importance of visceral obesity and insulin resistance. J Intern Med 2003; 254: 32–44PubMedCrossRefGoogle Scholar
  76. 76.
    Brooks B, Cistulli P, Borkman M, et al. Obstructive sleep apnoea in obese noninsulin-dependent diabetic patients: effect of CPAP treatment on insulin responsiveness. J Clin Endocrinol Metab 1994; 79: 1681–5PubMedCrossRefGoogle Scholar
  77. 77.
    Smurra M, Philip P, Taillard J, et al. CPAP treatment does not affect glucose-insulin metabolism in sleep apnoeic patients. Sleep Med 2001; 2: 207–13PubMedCrossRefGoogle Scholar
  78. 78.
    Hung J, Whiford E, Parsons R, et al. Association of sleep apnea with myocardial infarction in men. Lancet 1990; 336: 261–4PubMedCrossRefGoogle Scholar
  79. 79.
    Mooe T, Rabben T, Wiklund U, et al. Sleep-disordered breathing in women: occurrence and association with coronary disease. Am J Med 1996 Sep; 101(3): 251–6PubMedCrossRefGoogle Scholar
  80. 80.
    Shahar E, Whitney C, Redline S, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001 Jan; 163: 19–25PubMedGoogle Scholar
  81. 81.
    Shamsuzzaman A, Winnicki M, Lanfranchi P, et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 2002; 105: 2462–4PubMedCrossRefGoogle Scholar
  82. 82.
    Ohga E, Tomita T, Wada H, et al. Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1. J Appl Physiol 2003; 94(1): 179–84PubMedGoogle Scholar
  83. 83.
    Dyugovskaya L, Lavie P, Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 2002; 165: 934–9PubMedGoogle Scholar
  84. 84.
    Guilleminault C, Connolly S, Winkle R. Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol 1983; 52: 490–4PubMedCrossRefGoogle Scholar
  85. 85.
    Becker H, Koehler U, Stammnitz A, et al. Heart block in patients with sleep apnea. Thorax 1998; 53 Suppl. 3: S29–32PubMedCrossRefGoogle Scholar
  86. 86.
    Tilkian A, Guilleminault C, Schroeder J, et al. Sleep-induced apnea syndrome: prevalence of cardiac arrhythmias and their reversal after tracheostomy. Am J Med 1977 Sep; 63(3): 348–58PubMedCrossRefGoogle Scholar
  87. 87.
    Grimm W, Hoffman J, Menz V, et al. Electrophysiologic evaluation of sinus node function and atrioventricular conduction in patient with prolonged ventricular asystole during obstructive sleep apnea. Am J Cardiol 1996; 77: 1310–4PubMedCrossRefGoogle Scholar
  88. 88.
    Becker H, Brandenburg U, Peter J, et al. Reversal of sinus arrest and atrioventricular conduction block in patients with sleep apnea during nasal CPAP. Am J Respir Crit Care Med 1995; 151: 215–8PubMedGoogle Scholar
  89. 89.
    Javaheri S, Parker T, Wexler L, et al. Occult sleep disordered breathing in stable congestive heart failure. Ann Intern Med 1995; 122(7): 487–92PubMedGoogle Scholar
  90. 90.
    Wilcox I, McNamara S, Willson G, et al. Is sleep apnea a new prognostic marker in heart failure? Circulation 1995; 92: 1–274CrossRefGoogle Scholar
  91. 91.
    Sin D, Logan A, Fitzgerald F, et al. Effects of CPAP on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration. Circulation 2000; 102: 61–6PubMedCrossRefGoogle Scholar
  92. 92.
    Bassetti C, Aldrich M, Chervin R, et al. Sleep apnea in patients with transient ischemic attack and stroke: a prospective study of 59 patients. Neurology 1996; 47: 1167–73PubMedCrossRefGoogle Scholar
  93. 93.
    Dyken M, Somers V, Yamada T, et al. Investigating the relationship between stroke and obstructive sleep apnea. Stroke 1996; 27: 410–7CrossRefGoogle Scholar
  94. 94.
    Good D, Henkle J, Gelber D, et al. Sleep-disordered breathing and poor functional outcome after stroke. Stroke 1996; 27: 252–9PubMedCrossRefGoogle Scholar
  95. 95.
    Barbe F, Pericas J, Munoz A, et al. Automobile accidents in patients with sleep apnea syndrome. Am J Respir Crit Care Med 1998; 158: 18–22PubMedGoogle Scholar
  96. 96.
    Teran-Santos J, Jimenez-Gomez A, Cordero-Guevara J. The association between sleep apnea and the risk of traffic accidents: Cooperative Group Burgos-Santander. N Engl J Med 1999; 340: 847–51PubMedCrossRefGoogle Scholar
  97. 97.
    George C. Reduction in motor vehicle collisions following treatment of sleep apnoea with nasal CPAP. Thorax 2001; 56: 508–12PubMedCrossRefGoogle Scholar
  98. 98.
    American Thoracic Society. Sleep apnea, sleepiness and driving risk. Am J Respir Crit Care Med 1994; 150: 1463–73Google Scholar
  99. 99.
    Peker Y, Hedner J, Norum J, et al. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. Am J Respir Crit Care Med 2002; 166: 159–65PubMedCrossRefGoogle Scholar
  100. 100.
    He J, Keyger MH, Worick FJ, et al. Mortality and apnea index in obstructive sleep apnea: experience in 385 male patients. Chest 1988; 94: 9–14PubMedCrossRefGoogle Scholar
  101. 101.
    Partinen M, Jamieson A, Guillmeminault C. Long-term outcome for obstructive sleep apnea syndrome patients: mortality. Chest 1988; 94: 1200–4PubMedCrossRefGoogle Scholar
  102. 102.
    Peker Y, Hedner J, Kraiczi H, et al. Respiratory disturbance index: an independent predictor of mortality in coronary artery disease. Am J Respir Crit Care Med 2000; 162: 81–6PubMedGoogle Scholar
  103. 103.
    Flemons WW, Littner MR, Rowley JA, et al. Home diagnosis of sleep apnea: a systematic review of the literature. An evidence review co-sponsored by the American Academy of Sleep Medicine, the American College of Chest Physicians, and the American Thoracic Society. Chest 2003; 124(4): 1543–79PubMedCrossRefGoogle Scholar
  104. 104.
    Engleman H, Martin S, Douglas N. Compliance with CPAP therapy in patients with the sleep apnea/hypopnea syndrome. Thorax 1994; 49: 263–6PubMedCrossRefGoogle Scholar
  105. 105.
    Reeves-Hoche M, Meck R, Swillich C, et al. Nasal CPAP: an objective evaluation of patient compliance. Am J Respir Crit Care Med 1994; 149: 149–54PubMedGoogle Scholar
  106. 106.
    Engleman H, Asgari-Jirhandeh N, McLeod A, et al. Self reported use of CPAP and benefits of CPAP therapy: a patient survey. Chest 1996; 109: 1470–6PubMedCrossRefGoogle Scholar
  107. 107.
    Hoffstein V, Viner S, Mateika S, et al. Treatment of obstructive sleep apnea with nasal CPAP: patient compliance, perception of benefits and side effects. Am Rev Respir Dis 1992; 145: 841–5PubMedGoogle Scholar
  108. 108.
    Kreiger J. Long-term compliance with CPAP therapy in obstructive sleep apnea patients and in snorers. Sleep 1996; 19 (9 Suppl.): 136–43Google Scholar
  109. 109.
    Meurice J, Dore P, Paquesteau J, et al. Predictive factors of long-term compliance with nasal continuous positive airway pressure treatment in sleep apnea syndrome. Chest 1994; 105: 429–33PubMedCrossRefGoogle Scholar
  110. 110.
    Kaneko Y, Floras J, Usui K, et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 2003; 348: 1233–41PubMedCrossRefGoogle Scholar
  111. 111.
    Chervin R, Theut S, Bassetti C, et al. Compliance with nasal CPAP can be improved by simple interventions. Sleep 1997; 20: 284–9PubMedGoogle Scholar
  112. 112.
    Likar L, Panciera T, Erickson A, et al. Group education sessions and compliance with nasal CPAP therapy. Chest 1997; 111: 1273–7PubMedCrossRefGoogle Scholar
  113. 113.
    Jones D, Braid G, Wedzicha J. Nasal masks for domiciliary positive pressure ventilation: patient usage and complications. Thorax 1994; 49: 811–2PubMedCrossRefGoogle Scholar
  114. 114.
    Richards G, Cistulli P, Ungar R, et al. Mouth leak with nasal continuous positive airway pressure increases nasal airway resistance. Am J Respir Crit Care Med 1996; 154: 182–6PubMedGoogle Scholar
  115. 115.
    Scharf M, Brannen D, McDannold M, et al. Computerized adjustable vs fixed NCPAP treatment of obstructive sleep apnea. Sleep 1996; 19: 491–6PubMedGoogle Scholar
  116. 116.
    Stradling J, Barbour C, Pitson D, et al. Automatic nasal continuous positive airway pressure titration in the laboratory: patient outcomes. Thorax 1997; 52: 72–5PubMedCrossRefGoogle Scholar
  117. 117.
    Meurice J, Marc I, Series F. Efficacy of auto-CPAP in the treatment of obstructive sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1996; 153: 794–8PubMedGoogle Scholar
  118. 118.
    Reeves-Hoche M, Hudgel D, Meck R, et al. Continuous versus bilevel positive airway pressure for obstructive sleep apnea. Am J Respir Crit Care Med 1995; 151: 443–9PubMedGoogle Scholar
  119. 119.
    Piper A, Sullivan C. Effect of short-term NIPPV in the treatment of patients with severe obstructive sleep apnea and hypercapnia. Chest 1994; 105: 434–40PubMedCrossRefGoogle Scholar
  120. 120.
    Laursen S, Dreijer B, Hemmingsen C, et al. Bi-level positive airway pressure treatment of obstructive sleep apnoea syndrome. Respiration 1998; 65: 114–9PubMedCrossRefGoogle Scholar
  121. 121.
    Schafer H, Hasper E, Luderitz B. Failure of CPAP therapy in obstructive sleep apnoea syndrome: predictive factors and treatment with bilevel-positive airway pressure. Respir Med 1998; 92: 208–15PubMedCrossRefGoogle Scholar
  122. 122.
    Shepard J, Olsen D. Uvulopalatopharyngoplasty for treatment of OSA. Mayo Clin Proc 1990; 65: 1260–7PubMedCrossRefGoogle Scholar
  123. 123.
    Sasse S, Mahutte C, Kickeo M, et al. The characteristics of five patients with obstructive sleep apnea whose apnea-hypopnea index deteriorated after uvulopalatopharyngoplasty. Sleep Breath 2002; 6(2): 77–83PubMedCrossRefGoogle Scholar
  124. 124.
    Waite P, Wooten V, Lachner J, et al. Maxillomandibular advancement surgery in 23 patients with obstructive sleep apnea syndrome. J Oral Maxillofac Surg 1989; 47: 1256–61PubMedCrossRefGoogle Scholar
  125. 125.
    Riley R, Powell N, Guilleminault C. Obstructive sleep apnea syndrome: a review of 306 consecutively treated surgical patients. Otolaryngol Head Neck Surg 1993; 108: 117–25PubMedGoogle Scholar
  126. 126.
    Schmidt-Nowara W, Lowe A, Wiegand L, et al. Oral appliances for the treatment of snoring and obstructive sleep apnea: a review. Sleep 1995; 18: 501–10PubMedGoogle Scholar
  127. 127.
    Engleman H, McDonald J, Graham D, et al. Randomized crossover trial of two treatments for sleep apnea/hypopnea syndrome: CPAP and mandibular repositioning splint. Am J Respir Crit Care Med 2002; 166: 855–9PubMedCrossRefGoogle Scholar
  128. 128.
    Browman C, Sampson M, Yolles S, et al. Obstructive sleep apnea and body weight. Chest 1984; 85: 435–6PubMedCrossRefGoogle Scholar
  129. 129.
    Smith PL, Gold AR, Meyers DA, et al. Weight loss in mildly to moderately obese patients with obstructive sleep apnea. Ann Intern Med 1985; 103: 850–5PubMedGoogle Scholar
  130. 130.
    Noseda A, Kempenaers C, Kerkhofs M, et al. Sleep apnea after 1 year domiciliary nasal-continuous positive airway pressure and attempted weight reduction. Chest 1996; 109: 138–43PubMedCrossRefGoogle Scholar
  131. 131.
    Lojander J, Mustajoki P, Ronka S, et al. A nurse-managed weight reduction programme for obstructive sleep apnoea syndrome. J Intern Med 1998; 244: 251–5PubMedCrossRefGoogle Scholar
  132. 132.
    Rasheid S, Banasiak M, Gallagher SF, et al. Gastric bypass is an effective treatment for obstructive sleep apnea in patients with clinically significant obesity. Obes Surg 2003 Feb; 13(1): 58–61PubMedCrossRefGoogle Scholar
  133. 133.
    Jokic R, Klimaszewski A, Crossley M, et al. Positional treatment vs CPAP in patient with positional obstructive sleep apnea syndrome. Chest 1999; 115: 771–81PubMedCrossRefGoogle Scholar
  134. 134.
    Craig T, Teets S, Lehman E, et al. Nasal congestion secondary to allergic rhinitis as a cause of sleep disturbance and daytime fatigue and the response to topical nasal corticosteroids. J Allergy Clin Immunol 1998; 101: 633–7PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2005

Authors and Affiliations

  1. 1.Division of Pulmonary/Critical Care MedicineJohns Hopkins University DOMBaltimoreUSA

Personalised recommendations